Acura Pharmaceuticals

About:

Acura Pharmaceuticals develops and commercializes tamper-resistant products for medication abuse and misuse.

Website: http://www.acurapharm.com

Top Investors: Oxford Finance LLC

Description:

Acura Pharmaceuticals, Inc. is a specialty pharmaceutical company developing and commercializing tamper-resistant products to combat medication abuse and misuse. The Centers for Disease Control and Prevention estimates that one person dies every 19 minutes from prescription drug abuse in the United States. For nearly a decade, Acura has been at the forefront of developing solutions to combat this epidemic, with products utilizing the Company’s proprietary abuse-deterrent AVERSION® and IMPEDE® Technologies.

Total Funding Amount:

$10.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Palatine, Illinois, United States

Founded Date:

1935-01-01

Contact Email:

shareholder(AT)broadridge.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2014-08-27

IPO Status:

Public

Industries:

© 2025 bioDAO.ai